Nioi, M.; d’Aloja, E.; Fossarello, M.; Napoli, P.E.
Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns. Vaccines 2021, 9, 1274.
https://doi.org/10.3390/vaccines9111274
AMA Style
Nioi M, d’Aloja E, Fossarello M, Napoli PE.
Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns. Vaccines. 2021; 9(11):1274.
https://doi.org/10.3390/vaccines9111274
Chicago/Turabian Style
Nioi, Matteo, Ernesto d’Aloja, Maurizio Fossarello, and Pietro Emanuele Napoli.
2021. "Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns" Vaccines 9, no. 11: 1274.
https://doi.org/10.3390/vaccines9111274
APA Style
Nioi, M., d’Aloja, E., Fossarello, M., & Napoli, P. E.
(2021). Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns. Vaccines, 9(11), 1274.
https://doi.org/10.3390/vaccines9111274